ACURX PHARMACEUTICALS INC (ACXP)
US00510M1045 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A -100.00% | N/A | N/A 22.64% | N/A 245.80% | N/A 30.73% | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.93M | -4.6M 22.43% | -12.82M -178.70% | -12.09M 5.69% | -14.578M -20.58% | N/A 0.26% | N/A -79.99% | N/A 38.18% | N/A -137.36% | N/A 124.68% | N/A 104.34% | N/A 247.87% | N/A 74.46% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 29.59% | -1.14 6.08% | N/A 25.29% | N/A -74.85% | N/A -28.77% | N/A -69.15% | N/A -5.35% | N/A 58.81% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 50.38% | -0.39 -38.43% | -0.51 -96.15% | -0.60 -254.00% | -0.60 -227.78% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.213M 37.18% | -6.63M -51.44% | -8.67M -110.34% | -10.404M -268.73% | -10.404M -223.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.17 29.17% | -0.20 | 0.03 | 16.67% |
| Q2 2024 Q2Q % growth | -0.26 7.14% | -0.22 | -0.04 | -15.86% |
| Q1 2024 Q2Q % growth | -0.28 -12.00% | -0.24 | -0.04 | -14.38% |
| Q4 2023 Q2Q % growth | -0.37 -32.14% | -0.27 | -0.10 | -39.52% |
| Q3 2023 Q2Q % growth | -0.24 25.00% | -0.28 | 0.04 | 12.85% |
| Q2 2023 Q2Q % growth | -0.28 -7.69% | -0.28 | 0.00 | -1.67% |
| Q1 2023 Q2Q % growth | -0.25 3.85% | -0.30 | 0.05 | 16.92% |
| Q4 2022 Q2Q % growth | -0.28 -27.27% | -0.36 | 0.08 | 21.57% |
| Q3 2022 Q2Q % growth | -0.32 30.43% | -0.29 | -0.03 | -12.04% |
| Q2 2022 Q2Q % growth | -0.26 55.17% | -0.36 | 0.10 | 27.17% |
| Q1 2022 Q2Q % growth | -0.26 | -0.34 | 0.08 | 22.76% |
| Q4 2021 Q2Q % growth | -0.22 | -0.41 | 0.19 | 46.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 42.86% | 0% | 5.11% |
| Revenue | N/A | N/A | N/A | N/A |